Atypical Parkinsonism due to a D202N Gerstmann-Sträussler-Scheinker prion protein mutation: First in vivo diagnosed case

Movement Disorders

Volumn 28, Issue 2, 2013, Pages 241-245

  Plate, Annika ^a   Benninghoff, Jens ^a   Jansen, Gerald H ^b,c   Wlasich, Elisabeth ^a   Eigenbrod, Sabina ^a   Drzezga, Alexander ^d   Jansen, Nathalie L ^a   Kretzschmar, Hans A ^a   Bötzel, Kai ^a   Rujescu, Dan ^a   Danek, Adrian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Canadian Creutzfeldt Jakob Disease (CJD) Surveillance System and Prion Diseases Program   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Neurodegeneration; Parkinsonism; Prion disease

Indexed keywords

AMYLOID BETA PROTEIN; ASPARAGINE; ASPARTIC ACID; DESMETHOXYFALLYPRIDE F 18; DOPAMINE RECEPTOR STIMULATING AGENT; FLUORODEOXYGLUCOSE F 18; IODINE 123; IOFLUPANE I 123; LEVODOPA; NEURON SPECIFIC ENOLASE; PITTSBURGH COMPOUND B; PRION PROTEIN; PROTEIN S100B; RADIOPHARMACEUTICAL AGENT; ROPINIROLE; TAU PROTEIN; UNCLASSIFIED DRUG; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BEHAVIOURAL ASSESSMENT OF THE DYSEXECUTIVE SYNDROME; BRADYKINESIA; BRAIN METABOLISM; CASE REPORT; CAUCASIAN; CAUDATE NUCLEUS; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DAYTIME SOMNOLENCE; DEATH; DEPRESSION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DYSARTHRIA; DYSMETRIA; DYSPHAGIA; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPISODIC MEMORY; EYELID RETRACTION; FEEDING APPARATUS; FEMALE; FLUENCY DISORDER; GASTROTOMY; GENE MUTATION; GENOTYPE; GERMANY; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; HYPERREFLEXIA; HYPOKINESIA; IN VIVO STUDY; MEMORY DISORDER; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PARKINSON DISEASE; PERITONITIS; POLYSOMNOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RIGIDITY; SACCADIC EYE MOVEMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DISORDER; STEREOTYPY; THALAMUS; TIME MANAGEMENT; URINE INCONTINENCE; VERBAL MEMORY;

14-3-3 PROTEINS; AMYLOID BETA-PEPTIDES; ANTIPARKINSON AGENTS; CODON; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; HUMANS; INDOLES; MIDDLE AGED; MUTATION; NERVE GROWTH FACTORS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PEPTIDE FRAGMENTS; PHOSPHOPYRUVATE HYDRATASE; POLYSOMNOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; PRIONS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; S100 PROTEINS; TAU PROTEINS;

EID: 84874218408     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25188     Document Type: Article

References (20)

1. Gerstmann J. Über ein noch nicht beschriebenes Reflexphänomen bei einer Erkrankung des zerebellaren Systems. Wien Med Wochenschr 1928;78:906-908.
2. Gerstmann J, Sträussler E, Scheinker l. Über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems. Z Neurol 1935;154:736-762.
3. Hainfellner JA, Brantner-Inthaler S, Cerveníkov L, et al. The original Gerstmann-Sträussler-Scheinker family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 1995;5:201-211.
4. Kretzschmar HA, Honold G, Seitelberger F, et al. Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker. Lancet 1991;337:1160.
5. The Human Genome Mutation Database. Institute of Medical Genetics of the University of Cardiff. Gene symbol PRNP. Available at: http://www.hgmd.cf.ac.uk/ac/gene.php?gene=PRNP. Accessed August 26, 2012.
6. Piccardo P, Dlouhy SR, Lievens PM, et al. Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 1998;57:979-988.
7. Kong Q, Surewicz WK, Petersen RB, et al. Inherited prion diseases. In: Prusiner SB, ed. Prion Biology and Diseases. 2nd ed. Woodbury, NY, USA: Cold Spring Harbor Laboratory Press; 2004:673-776.
8. Fleming AB, Ghetti B, Murrell IR, et al. Gerstmann-Sträussler-Scheinker disease with progressive supranuclear palsy presentation. Dement Geriatr Cogn Disord 2010;30(Suppl 1):43.
9. Voon V. Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease. Mov Disord 2004;19:367-370.
10. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695-699.
11. Ufer K. Behavioural Assessment of the Dysexecutive Syndrome (German adaptation of Wilson BA, Aldeman N, Burgess P, Emslie H, Evans I. Bury St. Edmunds: Thames Valley Test Company; 1996). Göttingen: Hogrefe; 2000.
12. Hart J, Jr, Gordon B. Early-onset dementia and extrapyramidal disease: clinicopathological variant of Gerstmann-Straussler-Scheinker or Alzheimer's disease? J Neurol Neurosurg Psychiatry 1990;53:932-934.
13. Riemenschneider M, Wagenpfeil S, Vanderstichele H, et al. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry 2003;8:343-347.
14. Takahashi H, Iwata T, Kitagawa Y, et al. Increased levels of epsilon and gamma isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease. Clin Diagn Lab Immunol 1999;6:983-985.
15. Boellaard JW, Brown P, Tateishi J. Gerstmann-Straussler-Scheinker disease-the dilemma of molecular and clinical correlations. Clin Neuropathol 1999;18:271-285.
16. Yee RD, Farlow MR, Suzuki DA, Betelak KF, Ghetti B. Abnormal eye movements in Gerstmann-Straussler-Scheinker disease. Arch Ophthalmol 1992;110:68-74.
17. Montagna P. Fatal familial insomnia: a model disease in sleep physiopathology. Sleep Med Rev. 2005;9:339-353.
18. Provini F, Vetrugno R, Pierangeli G, et al. Sleep and temperature rhythms in two sisters with P102L Gerstmann-Straussler-Scheinker (GSS) disease. Sleep Med 2009;10:374-377.
19. Kepe V, Ghetti B, Farlow MR, et al. PET of brain prion protein amyloid in Gerstmann-Straussler-Scheinker disease. Brain Pathol 2010;20:419-430.
20. Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992;258:806-808.